MedTrace Logo

Prognostic Value of Biomarkers in Polyneuropathy.

NCT06044662 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-04-11

No results posted yet for this study

Summary

Biomarkers for prognosis of patients with polyneuropathy.

Conditions

  • Polyneuropathies

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-27
Primary Completion
2025-10-31
Completion
2026-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044662 on ClinicalTrials.gov